Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Adamis Pharmaceuticals CorpFinancial_Report.xls
10-K - ANNUAL REPORT - Adamis Pharmaceuticals Corpadmp-10k_033112.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - Adamis Pharmaceuticals Corpex31_1.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - Adamis Pharmaceuticals Corpex32_1.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - Adamis Pharmaceuticals Corpex32_2.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - Adamis Pharmaceuticals Corpex31_2.htm

 

 

Adamis Pharmaceutical Corporation 10-K

 

EXHIBIT 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

As independent registered public accountants, we hereby consent to the incorporation by reference in the following registration statements of our report dated June 29, 2012, included in Adamis Pharmaceutical Corporation's Form 10-K for the year ended March 31, 2012.

 

*    Registration statement on Form S-8, SEC file number 333-159229, as filed with the Securities and Exchange Commission on May 19, 2009,

 

*    Registration statement on Form S-8, SEC file number 333-169106, as filed with the Securities and Exchange Commission on August 30, 2010.

 

*    Registration statement on Form S-8, SEC file number 333-175383, as filed with the Securities and Exchange Commission on July 7, 2011.

 

 

/s/ Mayer Hoffman McCann P.C.  
   
MAYER HOFFMAN MCCANN PC  
Certified Public Accountants  
Boca Raton, Florida  

 

June 29, 2012